Company profile
AffinityImmuno company profile
AffinityImmuno provides R&D support services for biological drug research and discovery. The company specializes in antibodies, antibody lead generation, and offers a range of ELISA kits, including those for monitoring infliximab and pembrolizumab. AffinityImmuno also provides custom chicken polyclonal antibody services and immunogenicity assays, such as the SARS-CoV-2 spike protein-ligand binding assay for COVID-19 research. Their services are designed to support various stages of biological drug development.
Business identity
- Website
- https://affinityimmuno.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2014-01-01
Headquarters
- Headquarters
- Charlottetown, Prince Edward Island, Canada
- Postal code
- C1A 4P3
- Country code
- CA
- Continent
- North America